{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Fully Closed-Loop Versus Usual Care Glucose Control in Major Abdominal Surgery"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "In this two-centre, open-label, randomised controlled trial"
      },
      "Participants": {
        "score": 2,
        "evidence": "38 patients aged \u226518 years undergoing major abdominal surgery at University Hospital Bern and University Hospital Basel"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised (1:1) to FCL or UC glucose management"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluates the efficacy and safety of fully closed-loop (FCL) glucose control compared to usual care (UC) in this context."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the proportion of time with sensor glucose values in the target range of 5.6 to 10.0 mmol/L from hospital admission to discharge (max 20 days)."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Randomisation was performed using a minimization method"
      },
      "Blinding": {
        "score": 1,
        "evidence": "open-label with masked continuous glucose monitoring in the UC group"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "38 patients aged \u226518 years undergoing major abdominal surgery"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Thirty-seven patients were analysed (18 FCL, 19 UC) using a modified intention-to-treat approach."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The FCL group spent 80.1% \u00b1 10.0% of time in the target range compared to 53.7% \u00b1 19.7% in the UC group (P < 0.001). Mean glucose was 7.5 \u00b1 0.5 mmol/L in the FCL group and 9.1 \u00b1 2.4 mmol/L in the UC group (P = 0.015)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No study-related serious adverse events occurred."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "NCT05392452"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 18,
    "max_score": 25
  },
  "model": "gpt-4o"
}